🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Cue Biopharma, Inc. (CUE)
NASDAQ: CUE · Real-Time Price · USD
4.500
-0.260 (-5.46%)
At close: Nov 19, 2026, 4:00 PM EST
4.240
-0.260 (-5.78%)
After-hours: Nov 19, 2026, 7:59 PM EST

Cue Biopharma Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-206.68-26.6-40.67-50.73-53.01-44.16
Depreciation & Amortization
5.313.482.353.441.811.26
Other Amortization
0.010.040.040.040.03-
Loss (Gain) From Sale of Assets
-0.020.03-0.090.160-0.02
Loss (Gain) From Sale of Investments
-0.03-0.21--0.23-0.32-0
Stock-Based Compensation
59.974.746.858.189.511.52
Other Operating Activities
84.650.130.130.13-0.17-3.04
Change in Accounts Receivable
-4.75-4.60.75-1.643.09-1.73
Change in Accounts Payable
1.261.13-0.680.770.080.52
Change in Unearned Revenue
-7.825.25-2.032.11-0.65-7.97
Change in Other Net Operating Assets
16.98-5.07-2.97-2.18-2.174.79
Operating Cash Flow
-51.1-21.69-36.33-39.96-41.81-38.84
Operating Cash Flow Growth
------

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-0.12-0.18-0.07--0.17-0.91
Sale of Property, Plant & Equipment
0.020.040.100.010.02
Investment in Securities
70.21-25-24.4510
Investing Cash Flow
6.90.080.0325-24.619.11

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Long-Term Debt Issued
----10-
Long-Term Debt Repaid
--4.5-4-2--
Net Debt Issued (Repaid)
-1.5-4.5-4-210-
Issuance of Common Stock
32.6130.7914.2413.8639.319.98
Repurchase of Common Stock
-----0.2-0.75
Other Financing Activities
59.33---4.56-
Financing Cash Flow
90.4426.2910.2411.8653.6619.23

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Cash Flow
46.244.68-26.05-3.1-12.76-10.5

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-51.23-21.86-36.4-39.96-41.98-39.75
Free Cash Flow Growth
------
Free Cash Flow Margin
-143.74%-79.60%-391.89%-727.89%-3371.65%-266.04%
Free Cash Flow Per Share
-8.07-6.92-19.38-26.20-35.33-38.12
Levered Free Cash Flow
-76.02-9.95-20.36-19.91-21.09-20.32
Unlevered Free Cash Flow
-75.96-9.77-19.9-19.17-20.68-20.32

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
0.020.210.6710.57-
Cash Income Tax Paid
-----0.5
Change in Working Capital
5.68-3.3-4.93-0.930.36-4.39
SEC Filings: 10-K · 10-Q